8-KThe WireStrategic
Results of Operations
Filed Mar 11, 2026 · 4mo ago · Accession 0001193125-26-102170
Plain English
Tenaya Therapeutics, Inc. reported its financial results for the fourth quarter and full year ended December 31, 2025, and provided business updates. The company also announced a multi-target research collaboration with Alnylam Pharmaceuticals.
Filing details
- Company
- Tenaya Therapeutics, Inc.
- Ticker
- TNYA
- CIK
- 1858848
- Form type
- 8-K
- Filing date
- Mar 11, 2026
- Report date
- Mar 11, 2026
- Document
- tnya-20260311.htm
- Size
- 354 KB